mAb – Ingenious Biomolecules for a Wide Range of Applications
From Abciximab to Zolbetuximab – the list of therapeutic monoclonal antibodies (mAbs) is long and constantly growing. The need for reliable, scalable manufacturing systems is growing along with it. ZETA has been a leader in the development of technical solutions for liquid aseptic production systems for years. A track record of successfully completed projects underlines ZETA’s distinct advantage in the design of customized systems for mAb production.